Risk factors for HIV-2 infection in The Gambia. NLM AIDSLINE Important note: Information in this article was accurate in 1992. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Risk factors for HIV-2 infection in The Gambia.

AIDS. 1991 Sep;5(9):1127-32. Unique Identifier : AIDSLINE MED/92029732
Wilkins A; Hayes R; Alonso P; Baldeh S; Berry N; Cham K; Hughes A; Jaiteh K; Oelman B; Tedder R; et al; Medical Research Council Laboratories, The Gambia.

Abstract: A serosurvey was carried out to assess the prevalence of HIV infection in The Gambia and the importance of possible risk factors. The overall prevalence of HIV-2 infection among the 4228 adults studied was 1.7% while that of HIV-1 was 0.1%. The prevalence of HIV-2 was similar in both sexes but higher among those greater than 25 years of age and those who lived in two small towns along a main transport route. Among men, multivariate analysis showed prevalence of HIV-2 infection was significantly greater among those in the more affluent occupations, those without a secondary education and those with a history of urethral discharge. Among women, infection was more frequent in divorcees and widows and those who had been married several times. The prevalence was also higher in individuals born in Guinea-Bissau and in an ethnic group which originated there.
Keywords: Adolescence Adult Enzyme-Linked Immunosorbent Assay Female Gambia/EPIDEMIOLOGY Human HIV Infections/*EPIDEMIOLOGY/TRANSMISSION *HIV Seroprevalence HIV-1 *HIV-2 Male Middle Age Multivariate Analysis Prevalence Risk Factors Seroepidemiologic Methods Support, Non-U.S. Gov't JOURNAL ARTICLEKWDadolescenceadultenzyme-linkedimmunosorbentassayfemalegambia/epidemiologyhumanhivinfections/KWDepidemiology/transmissionKWDhivseroprevalencehiv-1KWDhiv-2malemiddleagemultivariateanalysisprevalenceriskfactorsseroepidemiologicmethodssupport,non-uKWDsKWDgov'tjournalarticle
920228
M9220832

Copyright © 1992 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1992. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .